1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on India Monoclonal Antibodies Market
4. Executive Summary
5. Voice of
Customer/Customer Insight
6. India Monoclonal
Antibodies Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Type (Murine, Chimeric,
Humanized, Human)
6.2.2. By Application (Cancer,
Cardiac/Cardiovascular, Neurological, Others)
6.2.3. By Production (In
vitro, In vivo)
6.2.4. By Biomanufacturing
(Originator, CMO)
6.2.5. By End users (Hospitals,
Research Laboratories, Others)
6.2.6. By Company
6.2.7. By Region
6.2.7.1.
By State (Top 3 States)
6.3.
Product Market Map
7. India Murine
Antibodies Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Application
7.2.2. By Production
7.2.3. By End users
8. India Chimeric
Antibodies Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Application
8.2.2. By Production
8.2.3. By End users
9. India Humanized
Antibodies Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Application
9.2.2. By Production
9.2.3. By End users
10. India Human
Antibodies Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Application
10.2.2. By Production
10.2.3. By End users
11.
Market Dynamics
11.1.
Drivers/Opportunities
11.2.
Challenges/Restraints
12.
Market Trends & Developments
13.
Policy & Regulatory Landscape
14.
India Economic Profile
15.
Import-Export Analysis
16.
Competitive Landscape
16.1.
Competition Outlook
16.2.
Company Profiles
16.2.1. Novartis India
Limited
16.2.2. Dr. Reddy’s
Laboratories Ltd.
16.2.3. Bristol Myers Squibb
India Pvt. Ltd.
16.2.4. Roche India Pvt.
Ltd.
16.2.5. Intas
Pharmaceuticals Limited
16.2.6. Merck India
16.2.7. Eli Lilly and
Company (India) Private Limited
16.2.8. Biocon Limited
16.2.9. AstraZeneca India
Pvt. Ltd.
16.2.10.
Pfizer Limited
17.
Strategic Recommendations
18.
About Us & Disclaimer